Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Multiple Myeloma
Novel CAR T-Cell Therapy Shows Promise in Relapsed or Refractory Multiple Myeloma
By
Charlie Dawson
Web Exclusives
,
Multiple Myeloma
Read More ›
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Breast Cancer
,
Pediatric Oncology
,
Multiple Myeloma
,
FDA Approvals, News & Updates
Read More ›
Daratumumab Therapy for Smoldering Myeloma Extends Progression-Free Survival
By
Wayne Kuznar
Web Exclusives
,
Multiple Myeloma
Read More ›
Lenalidomide plus Elotuzumab Maintenance Regimen Improves Responses in Multiple Myeloma
By
Wayne Kuznar
Web Exclusives
,
Multiple Myeloma
Read More ›
Daratumumab Added to Carfilzomib, Lenalidomide, and Dexamethasone: Safe and Tolerable in Patients with Newly Diagnosed Multiple Myeloma
By
Chase Doyle
Web Exclusives
,
Multiple Myeloma
Read More ›
CAR T-Cell Immunotherapy Makes Strides in Multiple Myeloma, with Durable Remission
By
Wayne Kuznar
Web Exclusives
,
Multiple Myeloma
Read More ›
Case Report: Intense Maintenance in a Woman with High-Risk Multiple Myeloma
Multiple Myeloma
Read More ›
Personalizing Myeloma Treatment Can Limit the Use of Expensive Drugs
Multiple Myeloma
Read More ›
It’s About Time: Monoclonal Antibodies for Multiple Myeloma
Multiple Myeloma
Read More ›
Lenalidomide as Maintenance in Transplant Myeloma Population Still Debated
Multiple Myeloma
Read More ›
Page 1 of 2
1
2